ODT stands for "oral dissolving tablet." You place it under your tongue and let it dissolve — don’t chew or swallow it whole. Avoid food and drinks for at least 30 minutes afterward so the medication can absorb properly. Take it at the same time each day for consistency, per your provider’s dosing schedule.

Both contain the same active ingredient. The injectable form has been more extensively studied in clinical trials and generally produces the most predictable bioavailability. Oral dissolving formulations are a practical alternative for women who are needle-averse or have injection anxiety. Your provider will set a dose that targets clinically meaningful weight loss and monitor your progress.

No needles, no syringes, no injection anxiety, no travel-with-sharps hassle. You can take your dose discreetly anywhere, anytime — perfect for frequent travelers, needle-phobic patients, or anyone who just prefers an easier experience. Many women tell us they started GLP-1 therapy only because they could skip the needles.

Yes. If you’re on injectable semaglutide and want to switch to ODT (or the other way around), your provider can evaluate whether the switch makes sense and adjust your dose. Message them through the Patient Portal to discuss.

ODT shares the same side effect profile as injectable semaglutide — nausea, mild heartburn, reduced appetite, possible constipation, fatigue during dose titration. Some patients find oral administration easier on the stomach, others find it similar. Your provider titrates slowly to minimize side effects.

Yes. Semaglutide — in any form — is a prescription medication. You complete a short online medical intake, a licensed provider reviews your history, and if you’re a fit, they write a prescription that ships directly to you from a state-licensed compounding pharmacy. No in-person visit required.